UNKNOWN EXTREMITY N/A

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2016-04-08 for UNKNOWN EXTREMITY N/A manufactured by Biomet Orthopedics.

Event Text Entries

[42316116] Current information is insufficient to permit conclusions as to the cause of the events. The following sections could not be completed with the limited information provided. Date of event - unknown. Device code - unknown. Expiration date - unknown. Date implanted - unknown. Date explanted - unknown. Initial reporter - the article was written by khoury et al in the journal of foot & ankle surgery (2012) 10. 1053/j. Jfas. 2012. 04. 014. Pma/510(k) number. Manufacture date? Unknown. (b)(4). Product location unknown.
Patient Sequence No: 1, Text Type: N, H10


[42316117] Information was received based on review of a journal article titled, "management of failed and infected first metatarsophalangeal joint implant arthroplasty by reconstruction with an acellular dermal matrix: a case report" which explored a new option of reconstructing the joint with an acellular dermal matrix substance in a single case study during a 12-month follow-up period. This study consisted of a (b)(6) year old female with a chief complaint of pain in the right first mtp joint with an onset of approximately 2 months previous to her presentation with no trauma to the area. The patient noted that her great toe had started to shorten and deform during that period. Ambulation seemed to make her pain and deformity worse. The patient experienced significant erythema and edema with what appeared to be an ulceration to the dorso-medial aspect of the joint. The initial radiographic examination revealed a koenig-type total joint, manufactured at biomet. Both phalangeal and metatarsal components were severely displaced with significant amounts of lucency noted at the stems of the implants. Complete dissolution of the proximal phalanx was noted, and the phalangeal stem was resting on top of the distal phalanx. Diagnosis was a failed total joint with concurrent ulceration and infection. Patient underwent debridement and removal of the total joint implant. In this case, the surgeon successfully incorporated the acellular dermal matrix into the first mtp joint after removal of the failed 2-component implant and resection of the necrotic proximal phalanx and distal first metatarsal bones. In conclusion, although current data are lacking on this approach, the results of this case have shown that adequate function, pain relief, and early weight-bearing can certainly be achieved.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number0001825034-2016-01198
MDR Report Key5562851
Date Received2016-04-08
Date of Report2016-03-10
Date Mfgr Received2016-03-10
Date Added to Maude2016-04-08
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. MEGAN HAAS
Manufacturer Street56 E. BELL DRIVE
Manufacturer CityWARSAW IN 46582
Manufacturer CountryUS
Manufacturer Postal46582
Manufacturer Phone5743726700
Manufacturer G1BIOMET ORTHOPEDICS
Manufacturer Street56 E. BELL DRIVE
Manufacturer CityWARSAW IN 46582
Manufacturer CountryUS
Manufacturer Postal Code46582
Single Use3
Previous Use Code3
Removal Correction NumberN/A
Event Type3
Type of Report0

Device Details

Brand NameUNKNOWN EXTREMITY
Generic NamePROSTHESIS, TOE
Product CodeKWH
Date Received2016-04-08
Model NumberN/A
Catalog NumberUNKNOWN EXTREMITY
Lot NumberUNKNOWN
ID NumberN/A
OperatorPHYSICIAN
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerBIOMET ORTHOPEDICS
Manufacturer Address56 E. BELL DRIVE WARSAW IN 46582 US 46582


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Required No Informationntervention 2016-04-08

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.